anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

203,041-203,100 of 319,975

filter-aware
14
Includes a diagram of the CAR-T structure, a waterfall plot for C-CAR031, and a tumor volume line chart for AZD0754.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
15
AstraZeneca branding at #AACR23 conference.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
16
Includes a quote from Stephen Fawell and a diagram illustrating epigenetic mechanisms (histone modification, DNA methylation, RNA interference).AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
17
Includes specific study references and definitions for abbreviations like TGI and PDX.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
18
AstraZeneca | Investor Conference Presentation Deck | 20 slidesAstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide acts as a summary of specific research presentations at AACR.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
20
AstraZeneca | Investor Conference Presentation Deck | 20 slidesAstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
01
Slide 1
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
02
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
03
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
04
Includes a photo of the CEO and a scientific illustration of a virus/cell structure.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
05
Includes a navigation bar at the top indicating this is the 'CEO Opening Remarks' section.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a horizontal stacked bar chart format to visualize revenue composition.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a progress-tracking visual to show specific drug candidates and their trial names/indications.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
08
Includes a headshot of the CFO and a scientific illustration related to the company's field.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
09
The slide uses a standard financial reporting format for quarterly results.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
10
The slide uses a standard P&L structure with CER (Constant Exchange Rate) change metrics.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Includes a waterfall chart for net debt and qualitative guidance for revenue and EPS.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The slide uses a horizontal process-like layout to show AI application across the value chain.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
13
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
14
The slide uses a navigation bar at the top to indicate the current section (Oncology).AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
15
The slide uses a matrix structure to map drug assets (Imfinzi, Tagrisso, Enhertu, etc.) against patient segments and clinical trial names.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
16
Includes Kaplan-Meier survival curves and bar charts for pCR rates.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
17
Slide 17 of a presentation deck. Includes detailed technical footnotes.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
18
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide uses a consistent color-coded legend for products within each business unit chart.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
20
R&I = respiratory and immunology. The slide uses a combination of bar charts for individual product trends and a donut chart for total revenue context.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
21
The slide uses a color-coded legend to indicate development status (launched, approved/launch prep, Phase III, Phase II, Phase I).AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
22
Slide 22 of a presentation deck.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
23
The slide uses a before-after comparison to highlight the speed advantage of AI in identifying antibody leads.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
24
The slide features a portrait of the CEO and a scientific illustration of molecular structures.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
25
Includes a stacked bar chart showing revenue trends by product over 7 quarters.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
26
Includes a stacked bar chart for Soliris registry data and a trial design schematic for gefurulimab.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
27
Includes a biological pathway diagram and a table of drug assets.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
28
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
29
The slide uses a two-column layout to contrast near-term R&D milestones with long-term corporate strategy.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
30
Slide 30 of a presentation, likely AstraZeneca given the executives listed.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
The slide highlights 5 regulatory approvals and 1 positive CHMP opinion.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
Includes progress against specific 2025/2026 targets.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
The chart illustrates the impact of COVID-19 medicine revenue on total Emerging Markets performance over time.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
Slide contains two distinct charts: a stacked bar chart for product sales and a grouped bar chart for collaboration revenue.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
39
Data presented as stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
Data reflects post-acquisition reporting for Alexion products.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Slide 1
ATAI | Investor Presentation Deck | 30 slidesATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations 1 hit
02
Includes a footer note regarding the update date of March 24th, 2023.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations 1 hit
03
The slide uses a numbered list to present five key pillars of the company's value proposition.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a hierarchical structure to connect a high-level objective to three specific strategic pillars.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
The slide uses a Gantt-style visualization to show drug development progress.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses a timeline format to communicate both past achievements and future R&D milestones.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
ATAI | Investor Presentation Deck | 30 slidesATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Loop · Golden Circle1 hit
08
Uses a timeline-style vertical flow to represent the 'need' metrics.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
Includes a quote from Keith Nuechterlein, Ph.D. regarding the clinical significance of the Symbol Coding results.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a vertical process flow to show the progression of clinical trials and data validation.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
11
The slide highlights the 'inverted-U' dose-response curve, a key pharmacological characteristic for this drug candidate.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
12
The slide highlights that lower doses of RL-007 (40 or 80 mg TID) show statistically significant improvements compared to placebo in cognitive endpoints.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit